Psilera Confirms PSIL-002, A New DMT Derivative, is Well-Tolerated and Non-Hallucinogenic...

Cybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products...

Editor’s Choice Award 2021-Best Study on Psychedelics and Nature

PT276 – Micah Haskell-Hoehl – Healing, Equity, and Federal Policy

Psychedelic Bulletin: MAPS’ $70m Investment Vehicle; atai’s Increased Stake in COMPASS;...

Psychiatrist and Addiction Researcher, Dr. Henry Kranzler Joins Entheon Advisory Board

Psyched Wellness Presents AME-1 to Health Canada in Pre-Submission Meeting

COMPASS Pathways announces further positive results from groundbreaking phase IIb trial...

Michael Falvey joins COMPASS Pathways as Chief Financial Officer

Silo Pharma Announces Grant of U.S. Patent For its Novel CNS...

Load more